0001415889-24-013652.txt : 20240517
0001415889-24-013652.hdr.sgml : 20240517
20240517215447
ACCESSION NUMBER: 0001415889-24-013652
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240503
FILED AS OF DATE: 20240517
DATE AS OF CHANGE: 20240517
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cho James
CENTRAL INDEX KEY: 0001891475
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38663
FILM NUMBER: 24962210
MAIL ADDRESS:
STREET 1: C/O GRITSTONE ONCOLOGY, INC.
STREET 2: 5959 HORTON STREET, SUITE 300
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Gritstone bio, Inc.
CENTRAL INDEX KEY: 0001656634
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5959 HORTON STREET, SUITE 300
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
BUSINESS PHONE: (510) 871-6100
MAIL ADDRESS:
STREET 1: 5959 HORTON STREET, SUITE 300
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
FORMER COMPANY:
FORMER CONFORMED NAME: Gritstone Oncology, Inc.
DATE OF NAME CHANGE: 20151023
4
1
form4-05182024_010540.xml
X0508
4
2024-05-03
0001656634
Gritstone bio, Inc.
GRTS
0001891475
Cho James
C/O GRITSTONE BIO, INC.
5959 HORTON STREET, SUITE 300
EMERYVILLE
CA
94608
false
true
false
false
SVP, CHIEF ACCOUNTING OFFICER
0
Common Stock
2024-05-03
4
A
0
10800
0
A
155123
D
Stock Option (Right to Buy)
0.96
2024-05-03
4
A
0
65400
0
A
2034-05-02
Common Stock
65400
65400
D
Represents Restricted Stock Units ("RSUs") of which 1/2 vests on September 30, 2024, with the remainder of grant vesting on July 31, 2025, subject to the continued service of the Reporting Person on each vesting date. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
Includes 72,415 RSUs which are subject to vesting.
The option vests as to 1/2 of the total grant on September 30, 2024, with the remainder of grant vesting on July 31, 2025, subject to the continued service of the Reporting Person on each vesting date.
/s/ James Cho
2024-05-17